Modulation of Attention in Event Related Potential (ERPs) as a Marker of

Status Active, not recruiting

Clinical Trial Summary

The objective of this study is to simultaneously establish the metrological characteristics of the new executive function markers (decision making and multiple flow management) derived from repeated ERP variations and to identify their ability to test whether a short treatment using Ginkgo biloba versus placebo extracts can modify the cognitive performance and functional capacity of patients in the very early stages of age-related cognitive decline. This trial, using subjects as their own control (cross-over) in repeated measurements will establish the reproducibility characteristics of the measurements and intra-individual variations of ERP over time in this population

Clinical Trial Description

This study is a single-center, randomized clinical trial testing the effects of Ginkgo biloba extracts versus placebo on event related potential ERP registration measurements in Electroencephalography (EEG) during neuropsychological tasks. The Hold-Release (HR) neuropsychological test allows the study of behavioral and neurofunctional correlates using several different techniques for online recording of brain activity. This test measures the engagement of focused attention and the loading of information into working memory, as opposed to the disengagement of attention. The study will be carried out in a randomized cross-over design, with "Ginkgo" vs. Placebo", or inversely, for 170 days each (approximately 6 months), separated by an 8-weeks wash-out period. A follow-up visit will be held 3 months after the last treatment of the study. The cross-over design uses each patient as its own control, which allows an easy comparison between the 2 groups "Placebo" vs. "Ginkgo" by limiting inter-patient variations. In addition, by doubling the number of patients per treatment compared to a classic study design in 2 groups, cross-over reduces the number of patients to be recruited, which facilitates recruitment on a single site. The study requires the recruitment of sixteen (16) informative participants with cognitive complaints. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04121728
Study type	Interventional
Source	University of Lausanne Hospitals
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 9, 2019
Completion date	May 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03516734` - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh	N/A
Not yet recruiting	`NCT05428228` - Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults	N/A
Completed	`NCT05073406` - Cognition at Altitude in HEMS - Part II	N/A
Completed	`NCT05498129` - School Feeding to Improve Cognitive Performance in Disadvantaged Children	N/A
Completed	`NCT05226039` - The Effects of a Single Bout of Aerobic Exercise on Cognition: The Moderating Role of Age	N/A
Completed	`NCT03169283` - Investigation of How Morning Nutrition Influences Cognitive Performance	N/A
Completed	`NCT01794351` - Cognitive Effects of 500mg Trans-resveratrol	N/A
Completed	`NCT02051153` - Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls	N/A
Completed	`NCT00607204` - Examining the Biological Factors That Affect Sleep Duration	N/A
Terminated	`NCT04056650` - Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers	Phase 4
Recruiting	`NCT05481424` - Evaluating the Potentials of Biodynamic Lighting for Home Office Workers	N/A
Completed	`NCT05281146` - Production of Fortified Biscuit With Chickpea and Crushed Peanut for Improving Cognitive Performance	N/A
Completed	`NCT00395668` - TETRA (Terrestrial Trunked Radio)	Phase 4
Active, not recruiting	`NCT03771716` - Rhythm Experience and Africana Culture Trial	N/A
Active, not recruiting	`NCT03567343` - Investigational Test of a New Sleep Supplement	N/A
Completed	`NCT05032729` - Nutritional Intervention to Enhance Sleep Quality and Quantity in Athletes	N/A
Completed	`NCT04676542` - The Effects of Externally Paced Exercise on Cognitive Performance and Stress in College Aged Students	N/A
Not yet recruiting	`NCT05904431` - The Effect of Cognitive Performance on Physical Performance in Adolescent Basketball Players
Completed	`NCT04974606` - Effect of Coffeeberry on Mood, Motivation and Cognitive Performance	N/A
Recruiting	`NCT05598047` - Executive Functioning Training Study	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba — AgilGinkgo

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms